Pan European Networks - Horizon 2020 - page 195

‘The future common strategic framework can only make EU research
and innovation funding more attractive and easy to access for participants
if the whole process is made more transparent and easier to follow up
on, even by inexperienced EC funding applicants.
‘EU funding needs to improve in terms of how best to cover the full
innovation cycle, which goes from research to practice, by analysing and
strategically prioritising the research topics and gaps in each area,
co-ordinating research calls in a complementary way, especially for
cross-cutting areas, and by further promoting the dissemination and
implementation of research findings.
‘Greater priority needs to be given to researcher-initiated projects. Further
co-ordination needs to be promoted on research topics and findings
between the bottom-up research projects, currently funded under the
European Research Council, and the top-down ones, currently funded
under the co-operation programmes, so that the advantages of both
approaches can be optimised and world class excellence in research
is achieved.
‘Indicators for monitoring EU research and innovation funding should
continue to focus on scientific quality, but also on dissemination of
findings, capacity building and knowledge transfer.’
Global co-operation
The EU is also taking steps abroad against illicit drugs. In July last year,
whilst on a visit to Peru, the then European commissioner for
development, Andris Piebalgs, announced €32m of funding to be
directed towards tackling illegal drugs. The EU anti-drug programme,
which runs until 2017, will support the Peruvian Government in the
implementation of the National Strategy to Fight against Drugs, and is
the most significant support to the country so far in this area.
Speaking about the new funding, Piebalgs said he was happy the EU
could provide support. He commented: “We believe that the fight against
partner project sought to determine ways to
reduce pressure on forensic labs by reducing
the analysis time of narcotics and explosive
materials, and enabling on-site evaluation.
Horizon 2020
According to DG Justice, the EU’s latest
research and innovation framework
programme will provide further funding to
support research into psychoactive substances,
including developing new testing methods. The
Societal Challenges ‘Health, demographic
change and wellbeing’ objective is expected to
provide such opportunities.
The EMCDDA also anticipates that Horizon 2020
will play a major role in EU drug-related research.
In 2011, during the Commission’s public
consultation on the R&I framework programme,
the Scientific Committee of the EMCDDA
outlined key priorities for Horizon 2020.
‘EU research and innovation funding that
maximises the benefits of acting at the EU level
is vital, particularly in cross-border research on
societal challenges, such as drug-related
research. There is a need for well co-ordinated
research across the EU, where common
research questions are answered. The use of
appropriate methods, designs and instruments,
both qualitative and quantitative, facilitates the
generation of more statistically powerful
samples and allows for robust comparisons.
H O R I Z O N 2 0 2 0 P R O J E C T S : P O R TA L
I S S U E S I X
195
A D D I C T I O N
The Seventh
Framework Programme
has supported a
research project into
the faster analysis
of narcotics
© felixioncool
1...,185,186,187,188,189,190,191,192,193,194 196,197,198,199,200,201,202,203,204,205,...244
Powered by FlippingBook